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Background: Acute exacerbations of chronic obstructive pulmonary disease (AE-COPD) neces-
sitating hospital admission have a major impact on patient outcome and management costs.
We examined temporal trends in AE-COPD-related hospital admissions in France between
1998 and 2007.
Methods: Data were obtained from the French national hospital discharge database for
patients aged at least 25 years. AE-COPD was identified with both a “narrow” and a “broad”
definition, according to the position (primary or associated) of diagnoses, in order to ensure
robustness.
Results: In 2007, among adults aged 25 years or more, the crude AE-COPD-related admission
rates were 23/10000 in men and 10/10000 in women using the narrow definition. Using the
broad definition, these rates were respectively 38 and 16/10000. With the narrow definition,
the annual number of AE-COPD-related admissions increased by 38% between 1998 and
2007, while in-hospital lethality decreased from 7.6% to 6.0%. The proportion of male patients
decreased from 72% to 68%. Similar trends were found using the broad definition. The age-stan-
dardized AE-COPD-related admission rate increased by 4.4% per year in women and by 1.6% per
year in men with the narrow definition, and by respectively 3.8% and 1.2% with the broad)1 55 12 53 30; fax: þ33 (0)1 41 79 68 11.
nte.fr (C. Fuhrman).
0 Elsevier Ltd. All rights reserved.
596 C. Fuhrman et al.definition. A strong seasonal pattern of admissions for AE-COPD was found, matching that of
general practitioners visits for influenza-like illness.
Conclusion: Hospitalization rates for AE-COPD have increased in France in recent years, espe-
cially among women. By contrast, AE-COPD-related in-hospital lethality has decreased.
ª 2010 Elsevier Ltd. All rights reserved.Introduction
The prevalence of chronic obstructive pulmonary disease
(COPD) ranges from5%to15% in industrializedcountries,1,2 and
the burden of COPD in terms of disability and mortality is
expected to rise.3 Reported management costs are highly
variable,butCOPD is clearly an important sourceofhealthcare
expenditure. In 1993, COPD was the second source of total
costs and the first source of direct medical costs among all
pulmonary disorders in the United States,4 while it accounted
for 3.5% of total medical expenditure in France in 2001.5
Attempts have been made to increase awareness of
COPD in the general population and also among doctors and
health authorities, and to improve COPD prevention, diag-
nosis and management.6 The final goal of these initiatives is
to reduce the morbidity, mortality and costs of COPD. In
France, the international GOLD initiative (Global Initiative
for Chronic Obstructive Lung Disease) has been relayed by
the health authorities, scientific societies, professional
bodies and patient associations. In 2005 the French Ministry
of Health launched a 5-year plan against COPD, with six
main priorities: to improve epidemiological knowledge of
COPD; to improve public information; to educate health-
care providers; to facilitate access to care and to improve
quality of care; to develop patient education and rehabil-
itation programs and structures; and to support research.7
International and French initiatives have underlined the
need to develop indicators for assessing the COPD burden
and for monitoring trends. AE-COPD-related hospital
admissions could serve as such an indicator, and may reflect
the impact of global and targeted preventive and thera-
peutic measures.
Acute exacerbations of COPD (AE-COPD) are major events
in the disease course, especially when they necessitate
hospitalization. Indeed, AE-COPD is associatedwith a decline
in lung function, impaired health-related quality of life, and
increased mortality.8,9 Hospitalizations for AE-COPD account
for a large proportion of COPD-related healthcare expendi-
ture. The French SCOPE study showed that, among patients
with diagnosed and treated COPD in the early 2000s, 41% of
total medical resource consumption was directly related to
COPD care, 34% to comorbid illnesses, and 25% to exacerba-
tions.10 The frequency and severity of AE-COPD could be
reduced by early diagnosis, education in self-management,
and home-based care.11,12
National hospital discharge databases are a useful
ongoing source of data on the burden of AE-COPD. However,
AE-COPD can be designated by various combinations of codes
of the International Classification of Diseases (ICD). A French
expert committee proposed two definitions for identifying
AE-COPD.13 The aim of this study was to document trends in
hospital admissions for AE-COPD between 1998 and 2007,
based on the French national hospital discharge database.Methods
Data sources
Data were extracted from the French hospital discharge
database (PMSI) for all patients aged 25 years or more
admitted from 1998 to the end of 2007 to hospitals located in
metropolitan France. The database covers all public and
private French hospitals. It includes both administrative data
(age, sex, zip code of the area of residence, admission and
discharge dates) and medical information, including primary
and associated diagnoses and vital status at discharge. To
ensure confidentiality, admission and discharge dates are
replaced with the length of stay (LOS) and the month of
discharge. Until 2009, the primary diagnosis was defined as
the diagnosis for which most medical resources were used.
Diagnoses are coded according to the ICD 10th revision (ICD-
10). As linkage between records for a given patient was not
available for the entire study period, the present analysis
focused on records rather than individuals. Records with
an LOS shorter than two days were excluded unless the
discharge status was “deceased”, in order to eliminate day
hospitalization and short stays for scheduled examinations.
Incidence rates of general practitioner (GP) visits for
influenza-like illness were provided by the French Senti-
nelles network (www.sentiweb.fr).14 Influenza-like illness
was defined as sudden onset of fever (39 C), with myalgia
and respiratory symptoms.
Definitions of AE-COPD
The two ICD10-based definitions of AE-COPD proposed by the
French expert committee are described in Table 1.13 These
two definitions differed in the place (primaryor associated)
of diagnoses. The “narrow” definition included records with
a primary diagnosis of AE-COPD (specific codes J44.0 or J44.1)
and those combining (i) a diagnosis ofCOPDoremphysemaand
(ii) a lower respiratory tract infection (LRTI) or acute respi-
ratory failure (ARF), with one of these codes (COPD, emphy-
sema, LRTI or ARF) being cited as the primary diagnosis. The
“broad” definition included all records with the previous
codes or combination of codes, without taking into account
the type of diagnosis (i.e. primary or associated), and records
with a primary diagnosis of COPD or emphysema (J44 or J43).
Statistical analysis
Population data provided by the French National Institute
for Statistics and Economic Studies (INSEE) were used to
calculate the crude and 5-year age-specific admission rates
for each calendar year. Age-standardized rates (direct
method) were calculated by applying the age-specific
hospitalization rates to the 2006 French population.
Table 1 Algorithm used to identify hospital admissions for COPD exacerbations.
Narrow definition - primary diagnosis of COPD with acute lower respiratory infection (J44.0)
or
- primary diagnosis of COPD with acute exacerbation, unspecified (J44.1)
or
- primary diagnosis of acute respiratory failure (ARF, J96.0) with an associated diagnosis of
emphysema (J43*) or COPD (J44*)
or
- primary diagnosis of acute lower respiratory infections (LRI, J10-J18, J20-J22) with an associated
diagnosis of emphysema (J43*) or COPD (J44*)
or
- primary diagnosis of emphysema (J43*) or COPD (J44*) with an associated diagnosis of ARF or LRI
Broad definition - primary diagnosis of emphysema (J43*) or COPD (J44*)
or
- associated diagnosis of COPD with acute lower respiratory infection (J44.0) or with acute
exacerbation (J44.1)
or
- ARF (J96.0) with emphysema (J43*) or with COPD (J44*), whatever the type of diagnosis
(i.e. primary or associated)
or
- LRI (J10-J18, J20-J22) with emphysema (J43*) or with COPD (J44*), whatever the type of diagnosis
(i.e. primary or associated)
Hospitalizations for exacerbations of COPD, 1998e2007 597Trends over timewere analyzed by using age-standardized
annual rates calculated for 12-month periods from1 July to 30
June of the following year, to take into account the seasonal
pattern of AE-COPD. The annual percentage changes (APC)
in hospitalization rates and their confidence intervals (CI)
were estimated with Poisson regression models. The models
included a linear time trend and a qualitative age effect. An
interaction term between sex and year was also introduced in
the model to test for between-gender differences in time
trends. The threshold of significance was set at 1%.
Results
Number of admissions and mortality
In 2006e2007 the mean annual numbers of AE-COPD-related
admissions were 65 983 using the narrow definition andTable 2 Characteristics of hospital admissions related to acute
years or more; France, 1998e2007.
Period
1998e9 2000e1
Mean annual number 47 977 49 112
Mean age (y), (sd) 72.0 (11.8) 72.0 (11.
Age groups, years (%)
25-44 2.3 2.3
45e64 20.5 20.4
6584 62.4 62.5
85 or more 14.8 14.8
Men (%) 72 72
Median LOSa (days), [IQR] b 10 [6e16] 10 [6e15
Records with an associated
diagnosis of asthma (%)
7.6 6.9
In-hospital mortality (%) 7.6 7.1
a LOS: length of hospital stay.
b IQR: interquartile range.107 511 using the broad definition, accounting for 1.6%e2.6%
of all admissions for medical (as opposed to surgical) diag-
noses among adults. The mean age of admitted patients was
73 years, regardless of the definition used; 68% of the
patients weremen, and themedian LOSwas 9 days (Table 2).
An associated diagnosis of asthma was noted in 6% of records
and was more frequent among women (10%) than men (4%).
The in-hospital lethality was 6% for the narrow definition
and 8% for the broad definition, and was higher among men
(6% and 9%, respectively) than among women (5% and 7%,
respectively).
Between 1998 and 2007 the annual number of hospital
admissions related to AE-COPD increased by 38% (narrow
definition) and 31% (broad definition). Using the narrow
definition, mean age increased from 72 to 73 years, while
the proportion of men decreased from 72% to 68%, the in-
hospital lethality decreased from 7.6% to 6.0%, and theexacerbation of COPD (narrow definition) in patients aged 25
2002e3 2004e5 2006e7
53 925 61 663 65 983
9) 72.4 (12.0) 72.9 (11.9) 73.3 (12.1)
2.2 1.9 1.9
20.2 20.0 20.4
63.8 64.3 61.7
13.8 13.8 16.0
71 70 68
] 10 [6e15] 9 [6e15] 9 [6e14]
6.6 6.5 6.1
7.5 6.7 6.0
598 C. Fuhrman et al.proportion of records mentioning asthma decreased from
7.6 to 6.1% (Table 2). Similar trends were found when the
broad definition was used (data not shown).
The frequency of ICD-10 codes specific for AE-COPD
(J44.0 and J44.1) increased between 1998 and 2007 (Fig. 1).
Hospitalization rates
From 1998 to the end of 2007, the crude annual admission
rates for AE-COPD increased among both men and women
(þ29% and þ60%, respectively, for the narrow definition
and þ22% and þ46%, respectively, for the broad definition).
In 2007 these rates were 23/10 000 among men and
10/10 000 among women when the narrow definition was
used, and respectively 38/10 000 and 16/10 000 with the
broad definition.
The age-specific rates of AE-COPD-related admissions
increased with age, particularly among adults aged 45 years
or more, up to 90 years (Fig. 2).
Whatever the definition used, the age-standardized
hospital admission rates for AE-COPD increased between
1998 and 2007 (Fig. 3). The interaction term between
gender and year of admission was statistically significant
(p < 0.001), with a more pronounced increase in women.
The annual percentage change (APC) was þ4.4 per year
[95% CI: 4.2e4.6] among women and þ1.6% [1.5e1.7]
among men when the narrow definition was used, and
respectively þ3.8 [3.6e3.9] and þ1.2% [1.1e1.3] when the
broad definition was used.
Seasonal pattern
Admissions for AE-COPD showed a strong seasonal pattern
(Fig. 4), being most frequent between December and April.
The height of the peaks varied year on year, the highest
peaks being observed in years with the highest rate of
general practitioner visits for influenza-like illness.
Discussion
This study shows that hospitalization rates for AE-COPD in
France increased between 1998 and 2007, especially amongFigure 1 Distribution of the different combinations of ICD-10 co
hospitalized for AE-COPD; France, 1998e2007.women. The seasonal pattern of hospitalization matched
the incidence of GP visits for influenza-like illness.
Validity of the use of a hospital discharge database
and ICD10 codes for identifying COPD
exacerbations
The French hospital discharge database was created in the
late 1990s, based on thediagnosis-relatedgroup (DRG) system
developed in the USA. The main objective was to provide
information on the activities of public and private hospitals,
for financial purposes (hospital funding), but the database
is also widely used for epidemiological monitoring.15,16
AE-COPD is particularly difficult to identify in healthcare
databases. Although ICD-10 provides a specific code (J44.0
or J44.1), AE-COPD can be also designated by various
combinations of diagnostic codes. In the French hospital
database, the primary diagnosis was defined as the diag-
nosis necessitating most medical resources. Co-morbidities
are frequent in COPD patients, and the primary diagnosis
recorded in the database may sometimes be a complication
occurring during the hospital stay rather than COPD. In
addition, coding practices may be influenced by changes in
diagnosis-related groups and their financial implications.
Lastly, day hospitalization and stays for scheduled exami-
nations are not identifiable in the French hospital database.
We therefore used two different indicators e a strict
definition and a broader definitione and excluded short stays
(less than 48 h) unless the patient died. Although the number
of hospitalizations differed somewhat according to the defi-
nition used, the temporal trends and characteristics of
hospitalization were very similar. The consistency with
seasonal trends in GP visits for influenza-like illness also
supports the validity of the algorithm used here to identify
AE-COPD, as viral infections play an important role in
AE-COPD.The trends observedusing thenarrowdefinitionare
therefore unlikely to be due to changes in coding practices.
Characteristics of hospitalization
The characteristics of hospitalization were consistent with
those found in two French clinical studies.17,18 In a cohort ofdes (narrow definition) among patients aged 25 years or more
Figure 2 Mean annual age-specific rates of hospital admission related to acute exacerbations of COPD in patients aged 25 years
or more; France, 2006e2007.
Hospitalizations for exacerbations of COPD, 1998e2007 5991824 patients admitted to medical wards for exacerbations
of COPD in 2006e2007, the sex ratio (76% men), mean age
(70 years) and mean length of stay (10 days) were similar to
those found here.17 In this latter study, the in-hospital
lethality was low (2.5%), probably because severely ill
patients who were admitted directly to an intensive care
unit and died before admission to a medical ward were not
included in the analysis. The in-hospital lethality in our
study was 6e7%, a value close to the 8% reported by Roche
et al,18 who recruited patients in emergency rooms,
providing less biased information on prognosis. Studies
based on hospital discharge databases in other countries
have shown in-hospital lethality of about 6e8%.19e21
Hospitalization rates and temporal trends
Acute lower respiratory tract infections and AE-COPD repre-
sent a major burden on the healthcare system during the
winter season. We found that the annual pattern of AE-COPD50
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Figure 3 Age-standardized rates of hospital admission related
to AE-COPD among patients aged 25 years or more; France, June
1998eJuly 2007. Rates are standardized to the 2006 French pop-
ulation and calculated from1july to 30 june of the following year.admissions showedmarked seasonal variations very similar to
those of GP visits for influenza-like illness. This seasonal
pattern of AE-COPD has already been described.22,23 Viral
infections have been found in more than 40% of patients with
AE-COPD,24,25 and viral respiratory tract infection is
an important trigger of severe AE-COPD.25,26 Recent data
show that influenza vaccination is associated with fewer
exacerbations and deaths among COPD patients.27 However,
although the cost of influenza vaccination is fully covered by
the French national health insurance system for people over
65 years and for patients with severe chronic respiratory
disease, it has been reported that only half of all patients
hospitalized for an acute exacerbation of COPD had been
vaccinated in the previous year.17
Wewere unable to study the possible correlation between
AE-COPD admissions and GP visits for influenza-like illnesses
because the date of admission was not available in the
hospital database. Nevertheless, it is important to consider
flu epidemic curves in order to avoid misinterpreting
AE-COPD admission trends. We therefore divided the study
period into 12-month periods, from1 July to 30 June, in order
to take into account the entire influenza epidemic period
when analyzing temporal trends in AE-COPD admissions.
Admissions rates for AE-COPD increased significantly
during the study period, especially among women, while
overall admissions rates for medical condition slightly
decreased during the same period (data not shown). Similar
trends in AE-COPD admissions have been observed in other
countries. The US National Hospital Discharge Survey (NHDS)
collects data annually from 500 hospitals. Hospitalization
rates for COPD (defined as a primary discharge diagnosis of
COPD or a primary diagnosis of acute bronchitis accompa-
nied by another listed diagnosis of COPD) increased between
1990 and 2000, and the gap between men and women
disappeared.28 Similar trends have been noted in Italy,
Australia and Canada.29e31 Between-gender differences in
these trends are consistent with global trends in tobacco use
and COPD epidemiology. In France, tobacco sales increased
until the first tobacco law in 1976. For the last 50 years, the
proportion of smokers has been increasing among women
while decreasing among men.32 As in other countries, COPD-
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Figure 4 a) Number of hospital admissions related to acute exacerbations of COPD (narrow definition) among patients aged 25
years or more; and b) weekly incidence of general practitioner visits for influenza-like illness (ILI); France, 1998e2007.
600 C. Fuhrman et al.related mortality has been increasing for the last 20 years in
women, while it recently stabilized in men.33,34 AE-COPD
admissions rates and COPD-related mortality rates are still
3e4 times higher in men in France.
Several factors may explain the observed increase in
hospital admissions for AE-COPD in France. One is a time-
related coding bias due to better COPD awareness. Diag-
nostic confusion between asthma and COPD has probably
become less frequent, as suggested by the decreasing
proportion of admissions for COPD with an associated
diagnosis of asthma. During the same period, the rates of
admissions for asthma decreased among adults35 but did
not match the increase in AE-COPD admissions rates. Thus
misclassification between asthma and COPD cannot fully
explain the increase in COPD admissions. Another potential
factor underlying the increase in admission numbers and
rates is an increase in readmissions. Indeed, in-hospital
lethality fell slightly during the study period (from 7.6% in
1998 to 6.0% in 2007), while mean age increased slightly,
suggesting better vital outcome of severe AE-COPD.
Improved patient management, and particularly the use of
non-invasive ventilation, probably explains these
trends.6,36,37
Global admission rates, by opposition to patient-based
admission rates, are important to assess the global burden of
a disease on the healthcare system and costs but are not
sufficient to weigh improvements in care. Better diagnosis
and more effective care, including the development of
home-based care, may reduce hospital admissions for
AE-COPD. On the other hand, better diagnosis (and thereforebetter coding) of COPD, and improved survival, would tend
to increase the number of admissions. Further studies with
linkage between hospital and national health insurance
databases (including vital status) should help to determine
the burden of readmissions and to assess treatment efficacy.
In conclusion, this study shows that hospitalization rates
for AE-COPD have increased in France in recent years, espe-
cially among women. Vital outcome of patients admitted for
AE-COPD has improved. Seasonal trends in hospital admis-
sions for AE-COPD tend to match those of GP visits for influ-
enza-like illness. Although the two ICD-10-based algorithms
used to identify AE-COPD in the French national hospital
discharge database seem to be sufficiently robust to follow
temporal trends, caution should be taken with regard to
misdiagnosis and coding bias.
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